Anti-Nogo-A therapy utilizes a novel monoclonal antibody, NG101, to stimulate the regeneration of damaged spinal cord tissue. By neutralizing growth-inhibiting proteins in the central nervous system, it enables severed nerve pathways to re-establish functional connections.#Neuroscience #Neurobiology #ClinicalNeurology #sflorghttps://www.sflorg.com/2026/05/ns05122601.html
